These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26402252)

  • 1. Identification of Biomarker and Co-Regulatory Motifs in Lung Adenocarcinoma Based on Differential Interactions.
    Zhao N; Liu Y; Chang Z; Li K; Zhang R; Zhou Y; Qiu F; Han X; Xu Y
    PLoS One; 2015; 10(9):e0139165. PubMed ID: 26402252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
    Zhang J; Le TD; Liu L; He J; Li J
    Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms.
    Chen Q; Hu H; Jiao D; Yan J; Xu W; Tang X; Chen J; Wang J
    Oncol Rep; 2016 Aug; 36(2):909-17. PubMed ID: 27277197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of microRNA and transcription factor synergistic regulatory network based on identifying regulatory motifs in non-small cell lung cancer.
    Li K; Li Z; Zhao N; Xu Y; Liu Y; Zhou Y; Shang D; Qiu F; Zhang R; Chang Z; Xu Y
    BMC Syst Biol; 2013 Nov; 7():122. PubMed ID: 24200043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems biology approach identifies key regulators and the interplay between miRNAs and transcription factors for pathological cardiac hypertrophy.
    Recamonde-Mendoza M; Werhli AV; Biolo A
    Gene; 2019 May; 698():157-169. PubMed ID: 30844478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.
    Yerukala Sathipati S; Ho SY
    Sci Rep; 2017 Aug; 7(1):7507. PubMed ID: 28790336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
    Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
    Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma.
    Cinegaglia NC; Andrade SC; Tokar T; Pinheiro M; Severino FE; Oliveira RA; Hasimoto EN; Cataneo DC; Cataneo AJ; Defaveri J; Souza CP; Marques MM; Carvalho RF; Coutinho LL; Gross JL; Rogatto SR; Lam WL; Jurisica I; Reis PP
    Oncotarget; 2016 May; 7(20):28920-34. PubMed ID: 27081085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
    Zhou LN; Li SC; Li XY; Ge H; Li HM
    Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers.
    Tran N; Abhyankar V; Nguyen K; Weidanz J; Gao J
    BMC Bioinformatics; 2018 Dec; 19(Suppl 20):504. PubMed ID: 30577741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of upregulated miR-136-5p in lung adenocarcinoma: A study of 1242 samples utilizing bioinformatics analysis.
    Li TT; Gao X; Gao L; Gan BL; Xie ZC; Zeng JJ; Chen G
    Pathol Res Pract; 2018 May; 214(5):750-766. PubMed ID: 29526559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentially Expressed miRNAs in Tumor, Adjacent, and Normal Tissues of Lung Adenocarcinoma.
    Tian F; Li R; Chen Z; Shen Y; Lu J; Xie X; Ge Q
    Biomed Res Int; 2016; 2016():1428271. PubMed ID: 27247934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating MicroRNA and transcription factor co-regulatory networks in colorectal cancer.
    Wang H; Luo J; Liu C; Niu H; Wang J; Liu Q; Zhao Z; Xu H; Ding Y; Sun J; Zhang Q
    BMC Bioinformatics; 2017 Sep; 18(1):388. PubMed ID: 28865443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transcriptional miRNA-gene network associated with lung adenocarcinoma metastasis based on the TCGA database.
    Wang Y; Han R; Chen Z; Fu M; Kang J; Li K; Li L; Chen H; He Y
    Oncol Rep; 2016 Apr; 35(4):2257-69. PubMed ID: 26781266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors.
    Mirzadeh Azad F; Naeli P; Malakootian M; Baradaran A; Tavallaei M; Ghanei M; Mowla SJ
    Gene; 2016 Feb; 577(2):221-6. PubMed ID: 26642897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oncogenic and prognostic potential of eight microRNAs identified by a synergetic regulatory network approach in lung cancer.
    Mitra R; Zhao Z
    Int J Comput Biol Drug Des; 2014; 7(4):384-93. PubMed ID: 25539849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a TF-miRNA-gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravis.
    Bo C; Zhang H; Cao Y; Lu X; Zhang C; Li S; Kong X; Zhang X; Bai M; Tian K; Saitgareeva A; Lyaysan G; Wang J; Ning S; Wang L
    Sci Rep; 2021 Jan; 11(1):2416. PubMed ID: 33510225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment.
    Xu X; Yu S; Sun W; Qin X; Chen Y; Zhou L; Lou R; Dong S; Shen B; Wu J; Zang J; Cao H; Shi M; Zhang Q; Feng J
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):431-438. PubMed ID: 29288364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.